ClinicalTrials.gg
Not yet recruitingNCT07921446PREVENT-DERSUpdated Nov 6, 2026

Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences

An interventional study of Lifestyle psychoeducation intervention and Personalized digital psychoeducation intervention on emotion regulation in Adverse Childhood Experience, Depression / Major Depressive Disorder and Anxiety Depression, sponsored by Institute of Mental Health, Singapore. Not yet recruiting. Open to participants aged 15 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Institute of Mental Health, Singapore · Not applicable, Interventional, and Prevention

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
15 Years to 35 Years
Sex
All
01

Study summary

The present study aims to determine whether a personalized digital psychoeducation intervention (active intervention group) is more effective than self-monitoring of one's mood (control group) in reducing emotion regulation difficulties, depression, anxiety, and stress symptoms in at-risk youths exposed to adverse childhood experiences (ACEs).

We hypothesized that the active intervention group will be associated with less severe emotion regulation difficulties, depression, anxiety, and stress symptoms than the control group at post-intervention and 3-month follow-up. This study will recruit a total of N = 140 youths (age 15 to 35 years) with ACEs and randomized into either the active intervention group (n = 70) or the control group (n = 70). Participants will complete study measures at baseline, post-intervention, and at 3-month follow-up. The study team has expertise in youth mental health. This study is feasible and will be completed within 4 years. Our findings will support the development and implementation of an efficacious, cost-effective, personalized and scalable intervention to reduce poor mental health and prevent the onset of mental disorders among at-risk youths. Our intervention has significant potential to improve population health, quality of life, functioning, morbidity, and mortality, as well as alleviate the healthcare burden associated with ACEs.

Read the detailed description

Specific aims:

This study aims to examine the efficacy of personalized digital psychoeducation to self-monitoring control (1) to reduce poor mental health as indexed by self-reported depression, anxiety, and stress symptoms at post-intervention and at 3-month follow-up; and (2) to reduce emotion dysregulation as indexed by momentary emotion regulation ability deficits and rumination severity at post-intervention in youths with elevated hypothesized risk (exposure to adverse childhood experiences (ACEs) and elevated levels of emotion dysregulation, or mild to moderate depression, anxiety or stress symptoms).

Hypotheses:

We hypothesized that (1) the active intervention group will be associated with less depression, anxiety, and stress symptoms than the control group at post-intervention and 3-month follow-up; (2) the active intervention group will be associated with less severe emotion dysregulation than the control group at post-intervention.

Methodology and approach:

This study will involve a two-arm, single-blinded, prospective (i.e., three time-points; baseline, post-intervention, 3-month follow-up), pilot randomized controlled trial. A total of N = 140 youths (age 15 to 35 years) with ACEs will be recruited and randomized into either the active intervention group (Personalized Psychoeducation + Self-Monitoring; n = 70) or the control group (Self-Monitoring; n = 70).

Feasibility:

The study team has clinical and research expertise in youth mental health. This study is supported by a multidisciplinary team of established clinician-scientists and researchers. It is expected that this study will be completed within four years.

Importance to science or medicine:

We aim to develop an efficacious, cost-effective, personalized, scalable, and accessible transdiagnostic intervention to reduce poor mental health and prevent the onset of mental disorders among youths exposed to ACEs. Our intervention has a significant public health impact due to positive downstream effects on improving population health, quality of life, functioning, morbidity, and mortality, as well as alleviating the healthcare burden due to ACEs.

02

Conditions studied

  • Adverse Childhood Experience
  • Depression / Major Depressive Disorder
  • Anxiety Depression
  • Anxiety

Keywords

  • Prevention
  • Emotion Regulation
  • Youth Mental Health
  • Adverse Childhood Experiences
  • Precision Psychiatry
  • Digital Interventions
  • Ecological Momentary Assessment
03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 140 is above the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Institute of Mental Health, Singapore is the lead sponsor of 18 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Exposed to at least one Adverse Childhood Experience (ACE)
  • Screened positive for elevated scores on the Difficulty with Emotion Regulation Scale (DERS) OR Ruminative Response Scale (RRS) OR mild to moderate scores on the Depression Anxiety and Stress Scales (DASS)
  • Aged 15 years to 35 years
  • Singapore citizens or permanent residents
  • Able to speak or understand English
  • Regular access to a smart phone or tablet with internet connection

Exclusion criteria

Exclusion Criteria:

  • Self-reported diagnosis of any mental disorder
  • Currently seeking mental health support from any mental health professional (i.e., psychiatrist, clinical psychologist, counsellor, etc.) for any mental health difficulties
  • Self-reported active suicidal behavior
  • Miss 2 consecutive intervention sessions
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Personalized digital psychoeducation intervention on emotion regulation

    In this active intervention arm, participants will undergo a 4-week (1 hour per session) online psychoeducation and skills training intervention focused on improving emotion regulation skills. We will tailor and personalize the 4-week intervention to each participant based on the Ecological Momentary Assessment-generated emotion regulation profiles at baseline. Emotion regulation profiles are mapped to 6 core areas (poor emotional awareness, poor emotional clarity, non-acceptance of emotional responses, difficulty in engaging in goal-directed behavior, impulsivity, and limited access to adaptive emotion regulation strategies) as outlined by the validated Difficulty in Emotion Regulation Scale (DERS) or DERS model.

    Behavioral: Personalized digital psychoeducation intervention on emotion regulation

  • Active comparator
    Lifestyle psychoeducation intervention

    In this Active Comparator arm, participants will undergo a 4-week (1 hour per session) online psychoeducation intervention focused on learning healthy lifestyle strategies. The purpose of this arm is to support the blinding process, where both arms appear to receive similar interventions. Further, the lifestyle psychoeducation intervention is an evidence-based prevention intervention for depression and anxiety.

    Behavioral: Lifestyle psychoeducation intervention

Interventions

  • BehavioralLifestyle psychoeducation intervention

    The Control Intervention is a 4-week (1 hour per session) online psychoeducation intervention focused on learning healthy lifestyle strategies. The first online session (Week 1) involves providing participants with a background of psychoeducation, adverse childhood experiences (ACEs), and mental health. The second online session (Week 2) involves teaching participants the importance of sleep hygiene. The third online session (Week 3) involves teaching participants the importance of a healthy diet. The fourth online session (Week 4) involves teaching participants the importance of exercise and providing an overview of outdoor activities in Singapore. Participants will undergo Ecological Momentary Assessment (EMA) self-monitoring of their emotions between each intervention session.

  • BehavioralPersonalized digital psychoeducation intervention on emotion regulation

    The Active Intervention is a 4-week (1 hour per session) online psychoeducation and skills training intervention focused on improving emotion regulation skills. The Active Intervention includes personalized and non-personalized syllabus. The non-personalized intervention syllabus includes the following content: Session 1 (Enhancing emotional awareness and clarity), Session 2 (Accepting emotional responses), Session 3 (Reducing impulsivity and engaging in goal-directed behavior), and Session 4 (Accessing emotion regulation strategies). The personalized syllabus is based on each participant's Ecological Momentary Assessment (EMA)-generated emotion regulation profiles at baseline. In general, for weaker areas, we will reduce the difficulty in the type of skills taught and provide more skills practice. For stronger areas, we will teach more advanced skills for the participant to explore. Participants will undergo EMA self-monitoring of their emotions between each intervention session.

06

What researchers measure

Primary outcomes

  1. Depression, Anxiety, and Stress as Assessed by DASS-21

    The 21-item Depression Anxiety and Stress Scales (DASS; Lovibond \& Lovibond, 1995) will be used to screen for mild to moderate depression, anxiety, and stress symptoms. The DASS will also be administered at post-intervention and at the 3-month follow-up. Each item is rated on a 4-point Likert scale ranging from 0 (Did not apply to me) to 3 (Applied to me very much); higher scores indicate more severe depression, anxiety, and stress symptoms. Each subscale comprises 7 items and the subscale scores will be summed and multiplied by 2 as per scoring guidelines. Hence, each subscale score will range from 0 to 42.

    Time frame: From enrollment to 3-month (post-intervention) follow-up

  2. Global Emotion Dysregulation as Assessed by the DERS-SF

    The 18-item Difficulties with Emotion Regulation Scale Short-Form (DERS-SF; Kaufman et al., 2016) will be used to screen for elevated levels of global emotion dysregulation. Global emotion dysregulation has 6 subscales: poor emotional awareness, poor emotional clarity, non-acceptance of emotional responses, difficulty in engaging in goal-directed behavior, impulsivity, and limited access to adaptive emotion regulation strategies. These subscales correspond to the 6 dimensions of the DERS model. Each item is rated a 5-point Likert scale ranging from 1 (Almost never) to 5 (Almost always); higher scores will indicate more severe global emotion dysregulation (scores range from 18 to 90).

    Time frame: From enrollment to 3-month (post-intervention) follow-up

  3. Ecological Assessment of Momentary Emotion Dysregulation

    Ecological momentary assessment (EMA) of emotion dysregulation in the following two areas: Rumination and emotion regulation abilities. Two EMA items to assess rumination in response to recent stressors since the previous beep (How much were you focusing on the stressors? How much were you focusing on your emotions due to the stressors?). Both items are rated on a 100-point visual slider scale from 0 (not at all) to 100 (extremely). 21 EMA items to assess for emotion regulation abilities. Each item is rated on a 5-point Likert scale ranging from 1 (not at all) to 5 (completely).

    Time frame: From baseline to the end of intervention at 4 weeks

  4. Rumination as Assessed by the RRS

    The 10-item Ruminative Response Scale short-form (RRS; Treynor et al., 2003) will be used to screen for elevated levels of rumination. Each item is rated on a 4-point Likert scale ranging from 1 (Almost never) to 4 (Almost always); higher scores indicate more severe rumination (scores range from 10 to 40).

    Time frame: From enrollment to 3-month (post-intervention) follow-up

Secondary outcomes

  1. Subjective Well-Being as Assessed by the WEMWBS

    The 14-item Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; Tennant et al., 2007) will be used to assess for subjective well-being. Each item is rated on a 5-point Likert scale ranging from 1 (None of the time) to 5 (All of the time); higher scores indicate better positive well-being.

    Time frame: From enrollment to the 3-month (post-intervention) follow-up

  2. Multi-Dimensional Impulsivity as Assessed by the UPPS-P

    The 20-item Urgency-Premeditation-Perseverance-Sensation Seeking-Positive Urgency scale (UPPS-P; Cyders et al., 2014) will be used to assess for multi-dimensional impulsivity and the subdomains include negative and positive urgency, lack of perseverance, lack of premeditation, and sensation-seeking. Each item is rated on a 4-point Likert scale ranging from 1 (Strongly Agree) to 4 (Strongly Disagree).

    Time frame: From enrollment to three-month (post-intervention) follow-up

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Widdershoven RLA, Wichers M, Kuppens P, Hartmann JA, Menne-Lothmann C, Simons CJP, Bastiaansen JA. Effect of self-monitoring through experience sampling on emotion differentiation in depression. J Affect Disord. 2019 Feb 1;244:71-77. doi: 10.1016/j.jad.2018.10.092. Epub 2018 Oct 6. PubMed 30321767 ↗
  • Topper M, Emmelkamp PM, Watkins E, Ehring T. Prevention of anxiety disorders and depression by targeting excessive worry and rumination in adolescents and young adults: A randomized controlled trial. Behav Res Ther. 2017 Mar;90:123-136. doi: 10.1016/j.brat.2016.12.015. Epub 2016 Dec 23. PubMed 28049069 ↗
  • Subramaniam M, Vaingankar JA, Tan B, Abdin E, Chang S, Tan Y, Samari E, Archana S, Chua YC, Lee JK, Tang C, Lee YP, Chong SA, Verma SK. Examining psychological distress among youth in Singapore: Insights from the National Youth Mental Health Study. Asian J Psychiatr. 2025 Mar;105:104405. doi: 10.1016/j.ajp.2025.104405. Epub 2025 Feb 17. PubMed 39987652 ↗
  • Subramaniam M, Abdin E, Seow E, Vaingankar JA, Shafie S, Shahwan S, Lim M, Fung D, James L, Verma S, Chong SA. Prevalence, socio-demographic correlates and associations of adverse childhood experiences with mental illnesses: Results from the Singapore Mental Health Study. Child Abuse Negl. 2020 May;103:104447. doi: 10.1016/j.chiabu.2020.104447. Epub 2020 Mar 12. PubMed 32171798 ↗
  • Saccaro LF, Giff A, De Rossi MM, Piguet C. Interventions targeting emotion regulation: A systematic umbrella review. J Psychiatr Res. 2024 Jun;174:263-274. doi: 10.1016/j.jpsychires.2024.04.025. Epub 2024 Apr 18. PubMed 38677089 ↗
  • Miu AC, Szentagotai-Tatar A, Balazsi R, Nechita D, Bunea I, Pollak SD. Emotion regulation as mediator between childhood adversity and psychopathology: A meta-analysis. Clin Psychol Rev. 2022 Apr;93:102141. doi: 10.1016/j.cpr.2022.102141. Epub 2022 Feb 21. PubMed 35219929 ↗
  • Mink F, Lutz W, Hehlmann MI. Ecological Momentary Assessment in psychotherapy research: A systematic review. Clin Psychol Rev. 2025 Apr;117:102565. doi: 10.1016/j.cpr.2025.102565. Epub 2025 Feb 28. PubMed 40068346 ↗
  • Liu J, Tan BCW, Abdin E, Padmini YS, Oh JY, Chong SA, Subramaniam M. Health care utilization, productivity losses, and burden of adverse childhood experiences in Singapore: Findings from a national survey. Psychol Trauma. 2025 Jan;17(1):1-9. doi: 10.1037/tra0001691. Epub 2024 Jun 20. PubMed 38900512 ↗
  • Bralee E, Mostazir M, Warren FC, Newbold A, Hulme C, Cranston T, Aas B, Bear H, Botella C, Burkhardt F, Ehring T, Fazel M, Fontaine JRJ, Frost M, Garcia-Palacios A, Greimel E, Hossle C, Hovasapian A, Huyghe VEI, Iversen N, Karpouzis K, Lochner J, Molinari G, Pekrun R, Platt B, Rosenkranz T, Scherer KR, Schlegel K, Schuller BW, Schulte-Korne G, Suso-Ribera C, Voigt V, Voss M, Watkins ER. Brief use of behavioral activation features predicts benefits of self-help app on depression symptoms: Secondary analysis of a selective prevention trial in young people. J Consult Clin Psychol. 2025 Apr;93(4):293-306. doi: 10.1037/ccp0000917. PubMed 40126557 ↗
  • Conejo-Ceron S, Bellon JA, Motrico E, Campos-Paino H, Martin-Gomez C, Ebert DD, Buntrock C, Gili M, Moreno-Peral P. Moderators of psychological and psychoeducational interventions for the prevention of depression: A systematic review. Clin Psychol Rev. 2020 Jul;79:101859. doi: 10.1016/j.cpr.2020.101859. Epub 2020 May 11. PubMed 32505982 ↗

Individual participant data

Plan to share: Yes — All de-identified IPD used in the results publication and subjected to formal approval by our governing ethics board.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: Beginning 1 year after publication with no end date

Access criteria: Researchers who contact the Principal Investigator and (1) submit a proposal that describes planned analyses (including but not limited to IPD meta-analysis, Intention-to-Treat (ITT) analyses based on pooled RCT data); and (2) sign a data sharing agreement; and (3) receive formal approval from our governing ethics board may be granted access to the de-identified IPD. Access to the de-identified IPD will be provided by the Principal Investigator and/or other methods (e.g., Trust Platform) as approved by our ethics boards and stated in the signed data sharing agreement.

Data sharing details ↗ · www.trustplatform.sg

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07921446
Lead sponsor
Institute of Mental Health, Singapore
Responsible party
Liu Jianlin (Dr. Liu Jianlin, Institute of Mental Health, Singapore) — Principal investigator
First posted
Nov 6, 2026
Start date
Dec 2026 (estimated)
Primary completion
Apr 2029 (estimated)
Completion
Apr 2030 (estimated)
Last update
Nov 6, 2026

Study contacts

JIANLIN LIU, Ph.D.
Contact
jianlinliu@nhghealth.com.sg
63893627
Mythily Subramaniam, Ph.D.
study director · Institute of Mental Health, Singapore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion